{ "cik": 1932393, "cik_padded": "0001932393", "entityName": "GE HealthCare Technologies Inc.", "fiscal_years": [ { "accn": "0001932393-26-000007", "filed": "2026-02-04", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "dividends_paid": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 200000000.0, "capex": 482000000.0, "cash": 4492000000.0, "cost_of_revenue": 12377000000.0, "dividends_paid": 64000000.0, "eps_diluted": 4.55, "free_cash_flow": 1505000000.0, "gross_profit": 8248000000.0, "net_income": 2084000000.0, "operating_cash_flow": 1987000000.0, "operating_income": 2763000000.0, "revenue": 20625000000.0, "stockholders_equity": 10379000000.0, "total_assets": 36906000000.0, "total_liabilities": 26307000000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "payout_ratio": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.3999030303030303, "leverage": 2.534637248289816, "net_margin": 0.10104242424242424, "operating_margin": 0.13396363636363637, "payout_ratio": 0.030710172744721688, "revenue_growth_yoy": 0.048444489629930865, "roa_avg2y": 0.05954711050789342, "roa_period_end": 0.05646778301631171, "roe_avg2y": 0.22140770252324038, "roe_period_end": 0.2007900568455535 } }, { "accn": "0001932393-26-000007", "filed": "2026-02-04", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "dividends_paid": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 401000000.0, "cash": 2874000000.0, "cost_of_revenue": 11467000000.0, "dividends_paid": 55000000.0, "eps_diluted": 4.34, "free_cash_flow": 1554000000.0, "gross_profit": 8205000000.0, "net_income": 1993000000.0, "operating_cash_flow": 1955000000.0, "operating_income": 2625000000.0, "revenue": 19672000000.0, "stockholders_equity": 8446000000.0, "total_assets": 33089000000.0, "total_liabilities": 24437000000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "payout_ratio": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.4170902806018707, "leverage": 2.8933222827373903, "net_margin": 0.10131150874339162, "operating_margin": 0.13343838958926393, "payout_ratio": 0.027596588058203714, "revenue_growth_yoy": 0.0061374795417348605, "roa_avg2y": 0.06081503745632638, "roa_period_end": 0.06023149687207229, "roe_avg2y": 0.2558572437255279, "roe_period_end": 0.23596968979398533 } }, { "accn": "0001932393-26-000007", "filed": "2026-02-04", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "dividends_paid": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 387000000.0, "cash": 2494000000.0, "cost_of_revenue": 11630000000.0, "dividends_paid": 41000000.0, "eps_diluted": 3.03, "free_cash_flow": 1714000000.0, "gross_profit": 7922000000.0, "net_income": 1568000000.0, "operating_cash_flow": 2101000000.0, "operating_income": 2435000000.0, "revenue": 19552000000.0, "stockholders_equity": 7133000000.0, "total_assets": 32454000000.0, "total_liabilities": 25144000000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "payout_ratio": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.4051759410801964, "leverage": 3.525024533856722, "net_margin": 0.08019639934533551, "operating_margin": 0.12453968903436989, "payout_ratio": 0.02614795918367347, "revenue_growth_yoy": 0.06602693419115642, "roa_avg2y": 0.05227276515593486, "roa_period_end": 0.048314537499229676, "roe_avg2y": 0.19017586416009702, "roe_period_end": 0.21982335623159957 } }, { "accn": "0001932393-25-000005", "filed": "2025-02-13", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "dividends_paid": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 310000000.0, "cash": 1440000000.0, "cost_of_revenue": 11162000000.0, "dividends_paid": 0.0, "eps_diluted": 4.22, "free_cash_flow": 1824000000.0, "gross_profit": 7179000000.0, "net_income": 1916000000.0, "operating_cash_flow": 2134000000.0, "operating_income": 2522000000.0, "revenue": 18341000000.0, "stockholders_equity": 9357000000.0, "total_assets": 27539000000.0, "total_liabilities": 17947000000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "payout_ratio": "ratio", "revenue_growth_yoy": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.39141813423477456, "leverage": 1.9180292828898151, "net_margin": 0.1044654053759337, "operating_margin": 0.1375061337985933, "payout_ratio": 0.0, "revenue_growth_yoy": 0.042991185669604776, "roa_period_end": 0.06957405860779259, "roe_period_end": 0.2047664849845036 } }, { "accn": "0001932393-24-000013", "filed": "2024-02-06", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cost_of_revenue": "USD", "dividends_paid": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD" }, "fundamentals": { "capex": 248000000.0, "cost_of_revenue": 10411000000.0, "dividends_paid": 0.0, "eps_diluted": 4.95, "free_cash_flow": 1359000000.0, "gross_profit": 7174000000.0, "net_income": 2247000000.0, "operating_cash_flow": 1607000000.0, "operating_income": 2795000000.0, "revenue": 17585000000.0 }, "period_end": "2021-12-31", "ratio_units": { "gross_margin": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "payout_ratio": "ratio" }, "ratios": { "gross_margin": 0.4079613306795564, "net_margin": 0.12777935740688087, "operating_margin": 0.1589422803525732, "payout_ratio": 0.0 } } ], "latest_filing": { "accn": "0001932393-26-000007", "filed": "2026-02-04", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "3844", "sic_description": "X-Ray Apparatus & Tubes & Related Irradiation Apparatus", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001932393.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001932393.json" }, "ticker": "GEHC" }